BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9368189)

  • 1. Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion.
    Tosello AC; Mary F; Amiot M; Bernard A; Mary D
    J Inflamm; 1998; 48(1):13-27. PubMed ID: 9368189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor zeta/ZAP-70-dependent and -independent signaling pathways in T cells.
    Deckert M; Ticchioni M; Mari B; Mary D; Bernard A
    Eur J Immunol; 1995 Jul; 25(7):1815-22. PubMed ID: 7542590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
    Skov S; Bregenholt S; Claesson MH
    J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
    Thome M; Duplay P; Guttinger M; Acuto O
    J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic cell phosphatase (HCP) regulates p56LCK phosphorylation and ZAP-70 binding to T cell receptor zeta chain.
    Raab M; Rudd CE
    Biochem Biophys Res Commun; 1996 May; 222(1):50-7. PubMed ID: 8630073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
    Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
    J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.
    Trevillyan JM; Lu YL; Atluru D; Phillips CA; Bjorndahl JM
    J Immunol; 1990 Nov; 145(10):3223-30. PubMed ID: 2172380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
    Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
    J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome.
    Scotese I; Gaetaniello L; Matarese G; Lecora M; Racioppi L; Pignata C
    Pediatr Res; 1998 Aug; 44(2):252-8. PubMed ID: 9702923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
    Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
    Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes.
    Nambiar MP; Enyedy EJ; Fisher CU; Warke VG; Juang YT; Tsokos GC
    Cell Immunol; 2001 Feb; 208(1):62-71. PubMed ID: 11277620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.
    Salvadori S; Zier K
    J Immunol; 1996 Apr; 156(8):2927-32. PubMed ID: 8609413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichosanthin inhibits T cell activation by interfering with the recruitment of ZAP-70 to CD3 zeta chain.
    Hong J; Fu SL; Shen ZY; Lu PH; Chou KY
    Cell Res; 1998 Mar; 8(1):33-9. PubMed ID: 9570015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.